生及其纯化主要成分在体外抑制临床相关的吸收和输出输送器
Tamás Varga1,2, Nóra Szilvásy2, Zsuzsanna Schelz3
1Doctoral School of Biology, ELTE Eötvös Loránd University, H-1117 Budapest, Hungary.
生提取物成分 [6]-gingerol 和 [6]-shogaol 与许多药物载体相互作用. 高剂量的生可能会通过影响OAT3.3等载体而与药物产生草药相互作用 (HDIs) 的风险.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 自然产品化学 自然产品化学
背景情况:
- 生 (Zingiber officinale) 被广泛用于医疗目的.
- 它通过药物载体对草药相互作用 (HDIs) 的潜力尚未得到充分研究.
研究的目的:
- 调查生提取物及其成分 ([6]-gingerol, [6]-shogaol) 与药物载体的相互作用.
- 为了评估生消费导致的高发性肠炎的风险.
主要方法:
- 使用过度表达输送体的细胞系和膜囊泡.
- 测量了与吸收和流出输送器的相互作用.
- 确定用于风险评估的IC50值.
主要成果:
- 生提取物与33个传送器中的17个相互作用.
- [6]-醇和 [6]-醇与7个和16个载体相互作用,分别.
- 确定了与OAT3,URAT1,OCT1,BSEP和ENT1的新型相互作用,其中 [6]-shogaol显示出强烈的OAT3抑制.
结论:
- 长时间服用高剂量的生可能会导致载体介导性HDIs.
- 与某些药物同时使用生补充剂需要谨慎.
- 建议进行进一步的体内研究以验证这些发现.
更多相关视频
11:27Methods to Study Epithelial Transport Protein Function and Expression in Native Intestine and Caco-2 Cells Grown in 3D
Published on: March 16, 2017
13:16Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles
Published on: December 31, 2019
相关概念视频
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Hepatic Drug Clearance: Role of Transporters
Drug Elimination by Renal Route: Tubular Secretion
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
